Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Melanie Wendy Castro-Mollo"'
Autor:
Katia Roque Perez, Melanie Wendy Castro-Mollo, Heberth Daniel Vallejos, Rossana Ruiz, Marco Galvez-Nino, Natalia Valdivieso, Ofelia Coanqui, Mivael Olivera Hurtado de Mendoza, Joan Perez, Aldo Lopez, Carlos Velarde, Ramon Andrade De Mello, Luis Mas
Publikováno v:
Journal of Clinical Oncology. 40:e17529-e17529
e17529 Background: Gestational trophoblastic neoplasia (GTN) is a rare tumor with an excellent prognosis. With the advent of multiagent chemotherapy, cure rate improved to nearly 100% in the low-risk group (LR). However, in developing countries it is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9631caab6f72f2f9ce8813ddee651c68
https://doi.org/10.1200/jco.2022.40.16_suppl.e17529
https://doi.org/10.1200/jco.2022.40.16_suppl.e17529
Autor:
Melanie Wendy Castro-Mollo, Alonso Diaz, Katia Roque Perez, Jessica Gabriela Meza, Shirley Milenca Quintana Truyenque, Estefanía Peña, Lourdes Lopez, Carlos Barrionuevo, Víctor Iván Mallma Soto, Daniela Dueñas, Cindy Elizabeth Alcarraz, Tatiana Vidaurre, Cesar Augusto Samanez, Jule F Vasquez
Publikováno v:
Journal of Clinical Oncology. 40:e19541-e19541
e19541 Background: Primary central nervous system lymphoma (PCNSL) is an aggressive and rare extranodal non-Hodgkin lymphoma with a dismal prognosis in most patients. Outcomes in Latin population is unknown. Methods: We present a retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9177b6f4e9ad57917d5fe2684db0536f
https://doi.org/10.1200/jco.2022.40.16_suppl.e19541
https://doi.org/10.1200/jco.2022.40.16_suppl.e19541